[Psychopharmacotherapy during pregnancy : Which antipsychotics, tranquilizers and hypnotics are suitable?].

about

[Psychopharmacotherapy during pregnancy : Which antipsychotics, tranquilizers and hypnotics are suitable?].

Item

http://www.wikidata.org/entity/Q50490346

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

[Psychopharmacotherapy during ...... and hypnotics are suitable?].

@en

[Psychopharmacotherapy during ...... and hypnotics are suitable?].

@nl

type

Item

label

[Psychopharmacotherapy during ...... and hypnotics are suitable?].

@en

[Psychopharmacotherapy during ...... and hypnotics are suitable?].

@nl

prefLabel

[Psychopharmacotherapy during ...... and hypnotics are suitable?].

@en

[Psychopharmacotherapy during ...... and hypnotics are suitable?].

@nl

P1476

[Psychopharmacotherapy during ...... and hypnotics are suitable?].

@en

P2093

N Bergemann

http://www.w3.org/2001/XMLSchema#string

W E Paulus

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring

The effects of benzodiazepine use during pregnancy and lactation

First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study

Promise and pitfalls of administrative data in evaluating pregnancy outcomes.

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data.

Clinical relevance of therapeutic drug monitoring during pregnancy.

Maternal use of antipsychotics in early pregnancy and delivery outcome.

Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.

Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy

Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy.

P2888

s00115-016-0192-z

P304

943-954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00115-016-0192-Z

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27573673

http://www.w3.org/2001/XMLSchema#string